tiprankstipranks
Immuron Sees Revenue Surge Amid Higher R&D Costs
PremiumCompany AnnouncementsImmuron Sees Revenue Surge Amid Higher R&D Costs
3M ago
Immuron plans Phase 2 trial for IMM-529 following FDA review
Premium
The Fly
Immuron plans Phase 2 trial for IMM-529 following FDA review
3M ago
Immuron announces new DoD research award for NMRC
Premium
The Fly
Immuron announces new DoD research award for NMRC
3M ago
Immuron files $15M mixed securities shelf
PremiumThe FlyImmuron files $15M mixed securities shelf
5M ago
Immuron requests pre-IND meeting for IMM-529
Premium
The Fly
Immuron requests pre-IND meeting for IMM-529
5M ago
Immuron announces board changes
Premium
The Fly
Immuron announces board changes
6M ago
Immuron says first patients enrolled in Campylobacter challenge clinical study
PremiumThe FlyImmuron says first patients enrolled in Campylobacter challenge clinical study
12M ago
Immuron begins clinical trial with second cohort in Travelan study
Premium
The Fly
Immuron begins clinical trial with second cohort in Travelan study
1y ago
Immuron enrolls first cohort of 30 participants into Travelan clinical trial
Premium
The Fly
Immuron enrolls first cohort of 30 participants into Travelan clinical trial
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100